Clinical Trial Update: A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, efficacy, and pharmacokinetics of mosunetuzumab alone and in combination with venetoclax for relapsed or refractory chronic lym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Mosunetuzumab (mosunetuzumab)
• Venetoclax (venetoclax)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Chronic Lymphocytic Leukemia | Phase 1 | Status: RECRUITING